Timp-2 as target/marker of beta cell failure

Details Timp-2 as target/marker of beta cell failure Timp-2 as target/marker of beta cell failure

G - Physics

01

N

G01N 33/68 (2006.01) G01N 33/573 (2006.01)

Patent

CA 2574417

The present invention relates to the monitoring of disease progression and diagnosis of beta-cell failure in diabetes by measuring levels of TIMP-2 in a liquid sample, and to screening for novel compounds for the prevention and/or treatment of diabetes.

La présente invention a trait au suivi de la progression de maladie et au diagnostic d'une défaillance de cellule bêta dans le diabète par la mesure de niveaux du TIMP-2 dans un échantillon liquide, et au criblage pour de nouveaux composés pour la prévention et/ou le traitement du diabète.

Affiliated with

Also associated with

Rating

Timp-2 as target/marker of beta cell failure does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Timp-2 as target/marker of beta cell failure, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Timp-2 as target/marker of beta cell failure will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1813798